• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2018年至2022年英国初级医疗中房颤(AF)和慢性肾脏病(CKD)患者护理及直接口服抗凝剂(DOAC)管理的差异:初级医疗哨点网络数据库研究

Disparities in the care and direct-acting oral anticoagulant (DOAC) management in atrial fibrillation (AF) and chronic kidney disease (CKD) in English primary care between 2018 and 2022: primary care sentinel network database study.

作者信息

Emanuel Subo, Field Benjamin Ct, Joy Mark, Fan Xuejuan, Williams John, Kaba Riyaz A, Lip Gregory Y H, de Lusignan Simon

机构信息

Department of Clinical and Experimental Medicine, University of Surrey Stag Hill Campus, Guildford, UK

Department of Clinical and Experimental Medicine, University of Surrey, Guildford, UK.

出版信息

Open Heart. 2025 May 21;12(1):e002923. doi: 10.1136/openhrt-2024-002923.

DOI:10.1136/openhrt-2024-002923
PMID:40398963
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12096997/
Abstract

BACKGROUND

In England, most prescribing of direct-acting oral anticoagulants (DOACs) for patients with chronic kidney disease (CKD) and atrial fibrillation (AF) takes place in primary care. The 2024 European Society of Cardiology guidelines introduced the AF-CARE ((C) comorbidities and risk factors; (A) avoid stroke and thromboembolism by appropriate prescription of oral anticoagulants; (R) rate and rhythm control; (E) evaluation and reassessment should be individualised for every patient, with a dynamic approach) framework to address this.

OBJECTIVE

To describe any health disparities in CKD and AF, including anticoagulation management and correct dosing of DOACs.

METHODS

Using English primary care sentinel network data from 2018 to 2022, demographics of AF and CKD including anticoagulation and appropriate DOAC dosing according to creatinine clearance and other factors were assessed. The study also examined disparities in CKD and AF in relation to socioeconomic status and ethnicity. We defined socioeconomic status by Index of Multiple Deprivation (IMD), a weighted composite index combining information from the domains of deprivation including income.

RESULTS

Of 10 513 950 people registered with general practices in the sentinel network, 2.9% (n=304 678) were aged ≥18 years with a diagnosis of AF. The prevalence of CKD in AF was 26.0% (n=79 210) and 63.3% of people eligible for anticoagulation were prescribed a DOAC. Among the 54 897 people with AF and CKD 3 or 4, greater likelihood of DOAC prescribing was associated with higher socioeconomic status. Socioeconomic disparities in anticoagulation increased through the 5 years. No association was identified between ethnicity and likelihood of being anticoagulated.In terms of correct dosing, there was no association with socioeconomic status. Overdosing was more frequent than underdosing. Incorrect dosing was associated with male sex (OR 0.80 (95% CI 0.74, 0.86)), dementia (OR 0.94 (0.83, 1.07)) and frailty (OR 0.42 (0.37, 0.48)).

CONCLUSIONS

People in the most deprived IMD quintile were least likely to be anticoagulated. Incorrect DOAC dosing was associated with male sex, increasing frailty and dementia. Socioeconomic and health disparities are apparent in anticoagulation prescribing and should be addressed in line with the AF-CARE framework.

摘要

背景

在英国,针对慢性肾脏病(CKD)合并心房颤动(AF)患者开具直接口服抗凝剂(DOACs)的处方大多在基层医疗中进行。2024年欧洲心脏病学会指南引入了AF-CARE((C)合并症和危险因素;(A)通过适当开具口服抗凝剂避免中风和血栓栓塞;(R)心率和节律控制;(E)评估和重新评估应针对每位患者进行个体化,并采用动态方法)框架来解决这一问题。

目的

描述CKD和AF患者中的任何健康差异,包括抗凝管理和DOACs的正确剂量。

方法

利用2018年至2022年英国基层医疗哨点网络数据,评估AF和CKD的人口统计学特征,包括抗凝情况以及根据肌酐清除率和其他因素确定的DOACs正确剂量。该研究还考察了CKD和AF在社会经济地位和种族方面的差异。我们通过多重剥夺指数(IMD)来定义社会经济地位,这是一个综合加权指数,结合了包括收入在内的剥夺领域信息。

结果

在哨点网络中注册全科医疗服务的10513950人中,2.9%(n = 3046

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/803d/12096997/72b90a50136b/openhrt-12-1-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/803d/12096997/1ecf742d0208/openhrt-12-1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/803d/12096997/320ffb3af9a4/openhrt-12-1-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/803d/12096997/1b2b2ef4a75b/openhrt-12-1-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/803d/12096997/18ecfd5092c3/openhrt-12-1-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/803d/12096997/72b90a50136b/openhrt-12-1-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/803d/12096997/1ecf742d0208/openhrt-12-1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/803d/12096997/320ffb3af9a4/openhrt-12-1-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/803d/12096997/1b2b2ef4a75b/openhrt-12-1-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/803d/12096997/18ecfd5092c3/openhrt-12-1-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/803d/12096997/72b90a50136b/openhrt-12-1-g005.jpg

相似文献

1
Disparities in the care and direct-acting oral anticoagulant (DOAC) management in atrial fibrillation (AF) and chronic kidney disease (CKD) in English primary care between 2018 and 2022: primary care sentinel network database study.2018年至2022年英国初级医疗中房颤(AF)和慢性肾脏病(CKD)患者护理及直接口服抗凝剂(DOAC)管理的差异:初级医疗哨点网络数据库研究
Open Heart. 2025 May 21;12(1):e002923. doi: 10.1136/openhrt-2024-002923.
2
Race/Ethnicity and Sex-Related Differences in Direct Oral Anticoagulant Initiation in Newly Diagnosed Atrial Fibrillation: A Retrospective Study of Medicare Data.种族/民族和性别相关的新发心房颤动直接口服抗凝剂起始差异:医疗保险数据的回顾性研究。
J Natl Med Assoc. 2020 Feb;112(1):103-108. doi: 10.1016/j.jnma.2019.10.003. Epub 2020 Feb 6.
3
Trends in direct oral anticoagulant (DOAC) prescribing in English primary care (2014-2019).英国初级医疗保健中直接口服抗凝剂(DOAC)处方的趋势(2014 - 2019年)
Heart. 2023 Jan 11;109(3):195-201. doi: 10.1136/heartjnl-2022-321377.
4
Prescribing Patterns of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Kidney Disease: A Retrospective Cohort Analysis.直接口服抗凝剂在伴有房颤和慢性肾脏病的患者中的处方模式:一项回顾性队列分析。
J Cardiovasc Pharmacol Ther. 2022 Jan-Dec;27:10742484221142220. doi: 10.1177/10742484221142220.
5
Correct dosing, adherence and persistence of DOACs in atrial fibrillation and chronic kidney disease: a systematic review and meta-analysis.直接口服抗凝剂在房颤和慢性肾脏病中的正确剂量、依从性和持久性:系统评价和荟萃分析。
Open Heart. 2023 Jul;10(2). doi: 10.1136/openhrt-2023-002340.
6
Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease.直接口服抗凝剂与华法林在预防慢性肾脏病房颤患者中风和全身性栓塞事件方面的比较
Cochrane Database Syst Rev. 2017 Nov 6;11(11):CD011373. doi: 10.1002/14651858.CD011373.pub2.
7
Management of atrial fibrillation in patients with chronic kidney disease in Europe Results of the European Heart Rhythm Association Survey.在欧洲,慢性肾脏病患者的心房颤动管理——来自欧洲心律协会调查的结果。
Europace. 2015 Dec;17(12):1862-7. doi: 10.1093/europace/euv416.
8
Systematic DOACs oral anticoagulation in patients with atrial fibrillation and chronic kidney disease: the nephrologist's perspective.在伴有慢性肾脏病的心房颤动患者中系统性 DOACs 口服抗凝治疗:肾病学家的视角。
J Nephrol. 2020 Jun;33(3):483-495. doi: 10.1007/s40620-020-00720-5. Epub 2020 Mar 21.
9
Efficacy and safety of direct oral anticoagulants in patients with atrial fibrillation and chronic kidney disease.直接口服抗凝剂在心房颤动合并慢性肾脏病患者中的疗效与安全性
Pacing Clin Electrophysiol. 2019 Nov;42(11):1463-1470. doi: 10.1111/pace.13811. Epub 2019 Oct 16.
10
Cardiorenal Outcomes Among Patients With Atrial Fibrillation Treated With Oral Anticoagulants.口服抗凝剂治疗的心房颤动患者的心脏肾脏结局
Am J Kidney Dis. 2023 Mar;81(3):307-317.e1. doi: 10.1053/j.ajkd.2022.07.017. Epub 2022 Oct 5.

本文引用的文献

1
CHA2DS2-VASc or a non-sex score (CHA2DS2-VA) for stroke risk prediction in atrial fibrillation: contemporary insights and clinical implications.用于心房颤动中风风险预测的CHA2DS2-VASc或非性别评分(CHA2DS2-VA):当代见解与临床意义。
Eur Heart J. 2024 Sep 29;45(36):3718-3720. doi: 10.1093/eurheartj/ehae540.
2
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).2024年欧洲心脏病学会(ESC)心房颤动管理指南,与欧洲心胸外科学会(EACTS)联合制定。
Eur Heart J. 2024 Sep 29;45(36):3314-3414. doi: 10.1093/eurheartj/ehae176.
3
Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference.
心房颤动患者的更长更好的生命:第 9 届 AFNET/EHRA 共识会议。
Europace. 2024 Mar 30;26(4). doi: 10.1093/europace/euae070.
4
Correct dosing, adherence and persistence of DOACs in atrial fibrillation and chronic kidney disease: a systematic review and meta-analysis.直接口服抗凝剂在房颤和慢性肾脏病中的正确剂量、依从性和持久性:系统评价和荟萃分析。
Open Heart. 2023 Jul;10(2). doi: 10.1136/openhrt-2023-002340.
5
Barriers and enablers to healthcare system uptake of direct oral anticoagulants for stroke prevention in atrial fibrillation: a qualitative interview study with healthcare professionals and policy makers in England.医疗保健系统对房颤卒中预防中直接口服抗凝剂的采用的障碍和促进因素:对英格兰医疗保健专业人员和政策制定者的定性访谈研究。
BMJ Open. 2023 Apr 25;13(4):e069575. doi: 10.1136/bmjopen-2022-069575.
6
Representativeness, Vaccination Uptake, and COVID-19 Clinical Outcomes 2020-2021 in the UK Oxford-Royal College of General Practitioners Research and Surveillance Network: Cohort Profile Summary.英国牛津-皇家全科医师学院研究和监测网络 2020-2021 年的代表性、疫苗接种率和 COVID-19 临床结局:队列简介摘要。
JMIR Public Health Surveill. 2022 Dec 19;8(12):e39141. doi: 10.2196/39141.
7
Deprivation in England, 1971-2020.1971年至2020年英国的贫困状况。
Appl Spat Anal Policy. 2023;16(1):461-484. doi: 10.1007/s12061-022-09486-8. Epub 2022 Nov 16.
8
Trends in direct oral anticoagulant (DOAC) prescribing in English primary care (2014-2019).英国初级医疗保健中直接口服抗凝剂(DOAC)处方的趋势(2014 - 2019年)
Heart. 2023 Jan 11;109(3):195-201. doi: 10.1136/heartjnl-2022-321377.
9
Temporal trends and patterns in atrial fibrillation incidence: A population-based study of 3·4 million individuals.心房颤动发病率的时间趋势和模式:一项基于340万个体的人群研究。
Lancet Reg Health Eur. 2022 Apr 25;17:100386. doi: 10.1016/j.lanepe.2022.100386. eCollection 2022 Jun.
10
Gender and Socioeconomic Inequality in the Prescription of Direct Oral Anticoagulants in Patients with Non-Valvular Atrial Fibrillation in Primary Care in Catalonia (Fantas-TIC Study).性别和社会经济不平等在非瓣膜性心房颤动患者在初级保健中的直接口服抗凝剂处方(Fantas-TIC 研究)在加泰罗尼亚。
Int J Environ Res Public Health. 2021 Oct 19;18(20):10993. doi: 10.3390/ijerph182010993.